Log In
BCIQ
Print this Print this
 

Qingtong, edaravone

  Manage Alerts
Collapse Summary General Information
Company Sihuan Pharmaceutical Holdings Group Ltd.
DescriptionEdaravone injection
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationPeripheral vascular disease (PVD)
Indication DetailsTreat peripheral vascular disease (PVD) in diabetes patients
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today